Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
about
Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.Early aberrant DNA methylation events in a mouse model of acute myeloid leukemia.Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice.IRX1 hypomethylation promotes osteosarcoma metastasis via induction of CXCL14/NF-κB signaling.The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancerCTL- vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma.Local production of the chemokines CCL5 and CXCL10 attracts CD8+ T lymphocytes into esophageal squamous cell carcinoma.Comparison of gene expression profiles and related pathways in chronic thromboembolic pulmonary hypertension.Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.The Expression of HSPD1, SCUBE3, CXCL14 and Its Relations with the Prognosis in Osteosarcoma.Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer.Evolving notions on immune response in colorectal cancer and their implications for biomarker development.CXCL14 and NOS1 expression in specimens from patients with stage I-IIIA nonsmall cell lung cancer after curative resection.Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I-III patients with colorectal cancer after operation
P2860
Q33771084-4F462AD6-C8E5-4EAF-8FFB-AF53FDD7D668Q33772607-E3267A11-48FA-47B8-9448-6C6379718944Q35172310-1FBD20FB-F03C-400E-9E19-D847E65540E3Q35719938-EDFE5D9D-7DC5-416B-BE38-4D4F87173A4AQ35754593-26E9AA62-07D4-4C34-89FD-7884E531B34CQ36027105-8FD92CAF-4781-4CA1-A86D-60A25EBF385FQ36413088-FB37BF99-FE11-4AEA-9F9B-FE649D71D4D1Q37496096-3225D2C2-72DC-4F30-92BA-46FC08FBC448Q37703500-F0FB1D58-D6F4-4E81-8DEA-870D06B38E4BQ38766777-1A83FB3A-5742-4BFE-9ED5-14DC822D911EQ41512848-E591EEB0-AD59-492C-8ED2-C2CB6B96C74EQ50098505-ACF4208B-1C73-454D-A188-EFF950381762Q51735301-5B150B44-CA8A-4877-9C3B-60B5A633D971Q54222467-E88D6359-9095-47AE-AF23-1E3D7B37B7F5Q57485832-D7BE3057-711E-45A3-9F0D-BC6DB80DA7E5
P2860
Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Chemokine CXCL14 is associated ...... noma after curative resection.
@ast
Chemokine CXCL14 is associated ...... noma after curative resection.
@en
type
label
Chemokine CXCL14 is associated ...... noma after curative resection.
@ast
Chemokine CXCL14 is associated ...... noma after curative resection.
@en
prefLabel
Chemokine CXCL14 is associated ...... noma after curative resection.
@ast
Chemokine CXCL14 is associated ...... noma after curative resection.
@en
P2093
P2860
P356
P1476
Chemokine CXCL14 is associated ...... noma after curative resection.
@en
P2093
Canhua Huang
Dandan Dong
Edouard C Nice
Fanghua Li
Longfei Deng
Quek Choon Lau
P2860
P2888
P356
10.1186/1479-5876-11-6
P577
2013-01-07T00:00:00Z
P5875
P6179
1012253886